本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tenaya Therapeutics Inc

0.5655
-0.0148-2.55%
盘后:0.5573-0.0082-1.45%19:54 EDT
成交量:251.47万
成交额:140.34万
市值:1.27亿
市盈率:-1.06
高:0.5774
开:0.5620
低:0.5450
收:0.5803
52周最高:2.35
52周最低:0.5211
股本:2.24亿
流通股本:2.23亿
量比:0.73
换手率:1.13%
股息:- -
股息率:- -
每股收益(TTM):-0.5333
每股收益(LYR):-0.5922
净资产收益率:-121.86%
总资产收益率:-47.91%
市净率:1.83
市盈率(LYR):-0.95

数据加载中...

2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/09

重要事件披露

Form 8-K - Current report
2024/07/25

重要事件披露

Form 8-K - Current report
2024/06/27

重要事件披露

Form 8-K - Current report
2024/05/31

重要事件披露

Form 8-K - Current report
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/03/18

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/18

重要事件披露

Form 8-K - Current report
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

重要事件披露

Form 8-K - Current report
2024/01/31

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/11/08

重要事件披露

Form 8-K - Current report